Covid: Molnupiravir sales may get hit amid safety concerns flagged by ICMR

Doctors say will prescribe if benefits outweigh risks; Clinicians also feel GoI should clarify its stand on Molnupiravir use

After the chief of India’s apex health research organisation said on Wednesday raised concerns around the safety of using oral antiviral drug molnupiravir, doctors felt that the government needs to clarify its stand. Also, industry sources said that prescription rates may go down among doctors after such safety concerns were raised.

Satyanarayana Mysore, HOD & Consultant-Pulmonology, Lung Transplant Physician and Karnataka Covid-19 task force member told Business Standard that it is strange that two arms of the government are not on the same page. He added that after the Drugs Controller General of India (DCGI) gave approval to a drug,